Order-of-magnitude gap: the company is already serving a demand source whose scale dwarfs its own current business
The model's full reasoning — Q2 2018 call → NOWe need to determine if management describes a mismatch of scale between the company and the demand it is already serving. The key is: is the company already inside a very large flow of activity, and does management explicitly draw the size contrast, treating it as a point? Looking at the transcript, management discusses various things: dispositions, same-site NOI, Toys "R" Us boxes, developments, etc. They talk about strong demand, leasing volume, occupancy. But do they describe a situation where the company is already serving a huge market relative to its size, and that even a modest share would make it several times bigger? They mention "demand match or exceed supply for high quality locations" and "retailers focusing on store growth in the top 20 markets". But that's general. They talk about the Toys "R" Us boxes being re-leased, but that's a specific set of properties, not a huge flow. They mention "the millenial generation coming into its peak spending years" and "40-year low for new supply" but that's macro. They talk about "signature series developments" that will deliver growth, but those are projects, not a current flow. The question asks: "does management convey that the company is currently supplying, serving, or participating in something whose size, spending, volume, or population is ENORMOUS RELATIVE TO THE COMPANY'S OWN CURRENT BUSINESS, such that even a modest further share of it would make the company several times bigger than it is today?" I don't see that. They talk about strong demand, but not about a specific large flow they are already inside. They talk about their portfolio being concentrated in top 20 markets, but that's not a mismatch of scale. They mention "the vibrant private market evaluations" and "disconnect between public and private pricing" but that's about asset sales. They talk about "the Toys liquidation" and re-leasing, but that's a limited number of boxes. They mention "the economy continuing to grow" and "demand from our retailers" but that's generic. There is no explicit statement like "we are only capturing a tiny fraction of a huge market" or "the potential is many times our current size". They do say "we are at a 40-year low for new supply" and "demand from our retailers continuing to increase" but that's not a mismatch.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| GDRX | GoodRx Holdings, Inc. | Q2 2022 | 2022-08-08 | F |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| HROW | Harrow Health, Inc. | Q4 2021 | 2022-03-10 | C |
| RELY | Remitly Global, Inc. | Q4 2021 | 2022-03-02 | B |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| HSTM | HealthStream, Inc. | Q3 2017 | 2017-10-24 | C |
HROW · Q4 2021 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...YES The transcript shows management describing Harrow as already inside the large cataract surgery market (4.5–6 million procedures annually) with real, present-tense participation: thousands of customer relationships, shipping north of two million sterile ophthalmic units last year, and touching roughly one million cataract surgeries. They explicitly contrast this scale against 2021 revenues of $72.5 million, noting that even a modest share of the pass-through-eligible market (1 million procedures × premium pricing) would produce “a big number” and drive revenues “more than double” in the near term. They treat the current business as only the “earliest sliver” of what they are already positioned inside, with the binding question being how much of the existing flow they can capture rather than whether the flow exists. This meets both criteria. The answer is YES. The transcript shows management describing Harrow as already inside the large cataract surgery market (4.
WRBY · Q1 2024 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...YES The transcript explicitly states that the company is already inside the optical industry with real business (245 stores serving customers, 83% of stores offering exams, 2.36 million active customers, and growing revenue from glasses, contacts, and exams). Management then draws the size contrast directly, noting that even the longer 900-store target "would still represent a small fraction of the 45,000 optical shops in the U.S." and that over 50% of major metro areas have only one store.
HSTM · Q3 2017 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...**YES** Management describes the company already being inside a much larger flow of activity (the 80 million-person healthcare workforce, of which 4.6 million are in post-acute settings) and explicitly treats the scale mismatch as the central point. They note their strong sales team is already a “steady contributor” to 4.